Range Low Price High Price Comment
30 days $0.0500 $0.0500 Monday, 4th Mar 2024 CFRX stock ended at $0.0500. During the day the stock fluctuated 0% from a day low at $0.0500 to a day high of $0.0500.
90 days $0.0457 $0.0620
52 weeks $0.0430 $3.95

Historical ContraFect Corporation prices

Date Open High Low Close Volume
2023-08-31 $0.751 $0.763 $0.720 $0.731 22 078
2023-08-30 $0.749 $0.751 $0.721 $0.740 11 676
2023-08-29 $0.711 $0.786 $0.700 $0.710 41 056
2023-08-28 $0.750 $0.750 $0.710 $0.718 33 353
2023-08-25 $0.81 $0.81 $0.690 $0.718 44 594
2023-08-24 $0.84 $0.85 $0.720 $0.770 52 871
2023-08-23 $0.89 $0.89 $0.80 $0.82 96 132
2023-08-22 $0.87 $0.87 $0.81 $0.85 67 348
2023-08-21 $0.89 $0.90 $0.86 $0.88 26 784
2023-08-18 $0.91 $0.92 $0.90 $0.91 18 032
2023-08-17 $0.93 $0.94 $0.88 $0.91 18 404
2023-08-16 $0.92 $0.97 $0.85 $0.91 40 694
2023-08-15 $0.99 $1.00 $0.91 $0.97 27 800
2023-08-14 $1.00 $1.00 $0.91 $0.96 59 125
2023-08-11 $1.00 $1.00 $0.96 $0.97 24 023
2023-08-10 $1.02 $1.02 $0.95 $0.96 31 297
2023-08-09 $1.01 $1.04 $0.95 $0.99 43 178
2023-08-08 $1.04 $1.07 $1.00 $1.03 37 416
2023-08-07 $1.10 $1.10 $1.02 $1.07 30 145
2023-08-04 $1.17 $1.18 $1.08 $1.11 37 530
2023-08-03 $1.10 $1.14 $1.09 $1.14 25 889
2023-08-02 $1.14 $1.13 $1.08 $1.10 40 322
2023-08-01 $1.19 $1.19 $1.12 $1.12 15 976
2023-07-31 $1.13 $1.17 $1.13 $1.17 33 214
2023-07-28 $1.11 $1.14 $1.09 $1.12 56 538
Click to get the best stock tips daily for free!

About ContraFect Corporation

ContraFect ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the in... CFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT